Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Abstract: Due to the demands for dynamic performance, model predictive control (MPC) has garnered significant attention in input-independent-output-parallel (IIOP) dual-active-bridge (DAB) converters.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...

Abstract: Taking human-robot collaborative assembly as an example, the methods based on contact forces can improve the assembly efficiency of industrial robots with large components in industrial ...